Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/118995
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Montraveta, Arnau |
dc.contributor.author | Xargay i Torrent, Sílvia |
dc.contributor.author | López Guerra, Mónica |
dc.contributor.author | Rosich, Laia |
dc.contributor.author | Pérez-Galán, Patricia |
dc.contributor.author | Salaverria Frigola, Itziar |
dc.contributor.author | Beà Bobet, Sílvia M. |
dc.contributor.author | Kalko, Susana |
dc.contributor.author | Frias, Mercè de |
dc.contributor.author | Campàs, Clara |
dc.contributor.author | Roué, Gaël |
dc.contributor.author | Colomer Pujol, Dolors |
dc.date | 2018-01-11T17:57:35Z |
dc.date | 2018-01-11T17:57:35Z |
dc.date | 2014-02-15 |
dc.date | 2018-01-11T17:57:35Z |
dc.identifier.citation | 1949-2553 |
dc.identifier.citation | 659704 |
dc.identifier.uri | http://hdl.handle.net/2445/118995 |
dc.format | 14 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Impact Journals |
dc.relation | Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.1455 |
dc.relation | Oncotarget, 2014, vol. 5, num. 3, p. 726-739 |
dc.relation | https://doi.org/10.18632/oncotarget.1455 |
dc.rights | cc-by (c) Montraveta, Arnau et al., 2014 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | Limfomes |
dc.subject | Medicaments |
dc.subject | Tumors |
dc.subject | Lymphomas |
dc.subject | Drugs |
dc.subject | Tumors |
dc.title | Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |